16 November 2026
Proposed Issue of Securities
European Metals Holdings Limited (ASX and AIM: EMH) (“European Metals” or the “Company”) advises that it proposes to issue a total of 625,000 new ordinary shares (represented by CHESS Depositary Interests or “CDIs”) (“New Ordinary Shares”) for nil consideration, at a deemed issue price of $0.12 per New Ordinary Share, in satisfaction of fees and interest payable under a loan facility on or around 20 November 2026.
Application will be made for the New Ordinary Shares represented by the CDIs to be admitted to trading on AIM ("Admission"), with Admission expected to take place on or around 20 November 2026. The New Ordinary Shares will rank pari passu in all respects with the existing ordinary shares in European Metals.
Total Voting Rights
Following Admission, the Company will have 238,443,705 ordinary shares on issue. There are no shares held in treasury. The total voting rights in the Company are therefore 238,443,705 and shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
ENDS
CONTACT
For further information on this update or the Company generally, please visit our website at www.europeanmet.com or see full contact details at the end of this release.
ENQUIRIES:
European Metals Holdings Limited Keith Coughlan, Executive Chairman Kiran Morzaria, Non-Executive Director Carly Terzanidis, Company Secretary | Tel: +61 (0) 419 996 333 Email: keith@europeanmet.com Tel: +44 (0) 20 7440 0647 Tel: +61 8 6245 2050 Email: cosec@europeanmet.com |
Zeus Capital Limited (Nomad & Broker) James Joyce/Darshan Patel/Jacob Walker (Investment Banking) Harry Ansell (Broking) | Tel: +44 (0) 203 829 5000 |
BlytheRay (Financial PR) Tim Blythe Megan Ray | Tel: +44 (0) 20 7138 3222 |
Chapter 1 Advisors (Financial PR - Aus) David Tasker | Tel: +61 (0) 433 112 936 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
